Inside the AI playbook Congress is putting together

ChatGPT and Midjourney finally forced Washington out of its comfort zone.

Following a policy framework introduced in May, the White House brokered voluntary safety commitments from leading AI labs in July, pushing for third-party auditing, cyber defense, and anti-misuse measures. Senate Majority Leader Chuck Schumer promised fast-track legislation, while a bipartisan push wants to draw a hard line: banning AI from ever making nuclear launch decisions.

Yet, knowing you want to regulate is very different from knowing how to write the code. Inside the Beltway, lawmakers are currently juggling proposals across four buckets: rules, institutions, funding, and talent.

From copyright fights to bioweapons

Right now, Capitol Hill is splitting its focus between immediate headaches and catastrophic tail risks.

On the immediate side, copyright and privacy dominate. The US Copyright Office has made it clear that machine outputs cannot be copyrighted as original works, while lawsuits pile up over training datasets. Privacy remains equally fraught; a vulnerability in March exposed ChatGPT chat logs and billing data, leading Italy to temporarily ban the service.

Meanwhile, the Algorithmic Accountability Act wants the FTC to actively police bias in machine learning systems, targeting algorithmic discrimination.

Then there are the extreme risks. Lawmakers are terrified of rogue models designing novel bioweapons or conducting automated cyberattacks. Senators Ted Budd and Ed Markey are pushing to mandate biological risk assessments from health agencies. Other proposals go even further, floating an FDA-style licensing regime where training runs and deployments require pre-market government approval.

The looming regulatory capture trap

Unsurprisingly, nobody agrees on how hard the hammer should drop.

Techno-libertarian groups like the Electronic Frontier Foundation (EFF) and the R Street Institute warn that sweeping licensing rules will backfire. Their main concern is regulatory capture: creating compliance hurdles so massive that only incumbents like OpenAI and Google can survive, killing open-source innovation in the process.

On the other side, Senators Josh Hawley and Richard Blumenthal want to strip liability shields, making AI builders directly vulnerable to civil lawsuits and criminal indictments if their models inflict harm.

At the same time, twenty-four governance researchers, including insiders from Google DeepMind and OpenAI, are calling for mandatory pre-release red-teaming, external audits, and heavy fines for violators.

Why it matters

If Washington goes down the FDA-style licensing path, open-source AI is the first casualty.

For enterprise giants, hiring hundreds of compliance officers and paying for mandatory third-party red teams is just an operating expense. For indie developers, open-source researchers, and early-stage startups, it is an insurmountable paywall. We think pushing for pre-market licensing under the banner of safety risks handing an accidental monopoly to the current market leaders.

For consumers, sweeping liability overhauls could mean safer and more privacy-conscious tools, but it will also mean slower rollouts. Platforms will aggressively sanitize model capabilities and limit autonomous agents simply to dodge catastrophic legal liability.

Washington is trying to regulate a technology moving at lightspeed using institutions that move at a glacial pace. If policymakers cannot separate catastrophic biological risks from routine software deployment, they risk breaking the software ecosystem entirely.